by NMS Group | Oct 22, 2021 | 2021, News
Nerviano, 22 October 2021 Nerviano Medical Sciences (NMS Srl,) a member of NMS Group and a pharmaceutical company developing innovative new chemical entities (NCE) for the treatment of cancers, today announces that the U.S. Food and Drug Administration (FDA) has...
by NMS Group | Feb 9, 2021 | 2021, News
Nerviano, 9 February 2021 NMS Group has been named the winner of the “Value creators’ category at the prestigious ‘China Awards 2021′ during the online event held by the Italy China Foundation on Monday 8 February 2021. The “Value creators’...
Welcome and Check out our new motion picture!
Recent Comments